Revvity Inc. (RVTY) is a Healthcare · Diagnostics & Research company listed on NYSE. Price $144.08 (-1.81%), Market cap $10.75B, P/E ratio 46.34, 52-week low–high $82.26 ~ $117.75.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable
Financial statements, price targets, institutional (13F) holdings and related news for Revvity Inc. are updated in real time on BlackAll Trade.
Revvity Inc. trades at $144.08 (-1.81%). Real-time quotes and charts are available on BlackAll Trade.
Revvity Inc. has a market cap of about $10.75B. Its P/E ratio is 46.34.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties